Insulin Sensitivity/Resistance Clinical Trials
2 recruiting trials for Insulin Sensitivity/Resistance. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Insulin Sensitivity/Resistance clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Institut de Recherches Cliniques de Montreal (1), Osaka Metropolitan University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Omega-3 fatty acids (dietary_supplement, 1 trial).
Track Insulin Sensitivity/Resistance trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk...
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Insulin Sensitivity/Resistance, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Insulin Sensitivity/Resistance, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Insulin Sensitivity/Resistance, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.